Synapse - Weinberg Fellows

Results (81)

MTAP loss by immunohistochemistry predicts worse survival and poor response to pemetrexed chemotherapy in pleural mesothelioma

Meeting Abstract

Saliba, M.; Arfe, A.; Baine, M.; Bodd, F.; Chang, J.; Ortiz, E.; Wilson, C.; Linkov, I.; Mayoral, M.; Offin, M.; more...
Laboratory Investigation (2025)

Fulltext@MSK | Save

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors

Journal Article

Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Ricciuti, B.; Digumarthy, S.; Alessi, J. V.; Gogia, P.; Pecci, F.; more...
Annals of Oncology (2025)

Fulltext@MSK | Save

Correlation of histologic features with gene alterations in pleural mesothelioma

Journal Article

Fanaroff, R. E.; Yang, S. R.; Tan, K. S.; Adusumilli, P. S.; Bodd, F.; Bowman, A.; Chang, J.; Offin, M. D.; Reiner, A.; Rekhtman, N.; more...
Modern Pathology (2025)

Fulltext@MSK | Save

Chromothripsis-mediated small cell lung carcinoma

Journal Article

Rekhtman, N.; Tischfield, S. E.; Febres-Aldana, C. A.; Lee, J. J. K.; Chang, J. C.; Herzberg, B. O.; Selenica, P.; Woo, H. J.; Vanderbilt, C. M.; Yang, S. R.; more...
Cancer Discovery (2025)

Fulltext@MSK | Save

Analysis of ASCL1/NEUROD1/POU2F3/YAP1 yields novel insights for the diagnosis of olfactory neuroblastoma and identifies sinonasal tuft cell–like carcinoma

Journal Article

Febres-Aldana, C. A.; Elsayad, M. M.; Saliba, M.; Bhanot, U.; Ntiamoah, P.; Takeyama, A.; Purgina, B. M.; Rodriguez-Urrego, P. A.; Marusic, Z.; Jakovcevic, A.; more...
Modern Pathology (2025)

Fulltext@MSK | Save

Brief report: Clinical characteristics and outcomes of patients with thoracic SMARCA4-deficient undifferentiated tumors

Journal Article

Cooper, A. J.; Arfe, A.; Ricciuti, B.; Gagné, A.; Sholl, L. M.; Di Federico, A.; Awad, M. M.; Aldea, M.; Ghigna, M. R.; Grecea, M.; more...
JTO Clinical and Research Reports (2025)

Fulltext@MSK | Save

Characteristics and outcomes of patients with SMARCA4-deficient undifferentiated thoracic tumors

Meeting Abstract

Cooper, A.; Ricciuti, B.; Gagne, A.; Sholl, L.; Di Federico, A.; Awad, M.; Aldea, M.; Ghigna, M. R.; Grecea, M.; Chaft, J.; more...
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save

Intratumoral escherichia is associated with improved survival to single-agent immune checkpoint inhibition in patients with advanced non–small-cell lung cancer

Journal Article

Elkrief, A.; Montesion, M.; Sivakumar, S.; Hale, C.; Bowman, A. S.; Begüm Bektaş, A.; Bradic, M.; Kang, W.; Chan, E.; Gogia, P.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer

Journal Article

Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
Clinical Cancer Research (2024)

Fulltext@MSK | Save

Osimertinib, platinum, etoposide as initial treatment for patients with EGFR mutant lung cancers with TP53 and RB1 alterations

Meeting Abstract

Chen, M. F.; Rakhade, S.; Quintanal-Villalonga, A.; Lee, J.; Forsythe, B.; Moses, K. A.; Ahn, L. S. H.; Pupo, A.; Falcon, C. J.; Rekhtman, N.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save